Highlights Qiagen N.V.

Equities

QGEN

NL0015001WM6

Market Closed - Nyse Other stock markets 01:30:02 26/06/2024 am IST			5-day change	1st Jan Change
41.04 ^USD	-2.36%		-6.19%	-8.34%

21/06	Qiagen Seeks M&A	CI
21/06	Transcript : Qiagen N.V. - Shareholder/Analyst Call

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Qiagen Seeks M&A	21/06	CI
Sartorius on the downswing again - low since 2020 is approaching	19/06	DP
Frankfurt shares close: Dax recovers	17/06	DP
Dpa-AFX Overview: COMPANIES from 17.06.2024 - 15:15	17/06	DP
Qiagen Targets 7% Annual Sales Growth Through 2028	17/06	MT
Qiagen eyes sales growth of 7% per year until 2028	17/06	RE
QIAGEN Announces the Release of A New Version of Its Clinical Decision Support Software, QCI Interpret	14/06	CI
Qiagen Scraps NeuMoDx 96, 288 Molecular Systems; Raises 2024 Adjusted Earnings Outlook	07/06	MT
Qiagen N.V. Reaffirms Earnings Guidance for the Second Quarter of 2024	07/06	CI
Qiagen N.V. Launches Digital PCR Assay Design Tool for QIAcuity, Expands Customization Capabilities of Its Research Platform GeneGlobe	06/06	CI
Qiagen Expands Qiastat-Dx Syndromic Testing Menu in the U.S. with Launch of Molecular Test to Improve Gastrointestinal Care	03/06	CI
Qiagen, Myriad Genetics Team Up to Develop Homologous Recombination Deficiency Test	31/05	MT
Qiagen, Myriad Genetics Partner to Create Easily Distributable Cancer Tumor Test	31/05	MT
QIAGEN and Myriad Genetics Develop Distributable Homologous Recombination Deficiency Test for Global Research and Companion Diagnostics Applications	31/05	CI
Qiagen N.V. Launches New Library Preparation Kit, Facilitating Multiomic Studies and Advancing Precision Medicine	30/05	CI
Qiagen's Updated Clinical Decision Support Platform Secures EU Certification	15/05	MT
QIAGEN Receives European IVDR Certification for QIAGEN Clinical Insight Interpret	15/05	CI
Qiagen Receives FDA Clearance for Qiastat-Dx Respiratory Syndromic Testing Panel for Fast and Accurate Results	13/05	CI
Qiagen, US FBI to Jointly Develop Digital PCR Assay for Forensics	08/05	MT
QIAGEN Partners with FBI to Develop Digital PCR Assay for QIAcuity for Use in Forensics	08/05	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

QIAGEN : A decent start to 2024; guidance unchanged

April 30, 2024 at 07:02 pm IST